{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:07:45Z","timestamp":1789967265828,"version":"4.0.1"},"reference-count":8,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"\n Background<\/jats:title>\n Primary malignant melanoma of the uterine cervix (PMMC) is an exceptionally rare mucosal malignancy with an aggressive clinical behavior and no established standard of care. Distinguishing a primary cervical melanoma from metastatic disease is particularly challenging and requires integration of pathological findings with comprehensive evaluation for an alternative primary site.<\/jats:p>\n <\/jats:sec>\n \n Case presentation<\/jats:title>\n \n We report a 67-year-old postmenopausal woman presenting with vaginal bleeding and an apparently benign endocervical polyp. Histopathological and immunohistochemical examination established the diagnosis of malignant melanoma, with diffuse SOX10, melanoma cocktail, and PRAME positivity and a Ki-67 proliferation index of approximately 40\u201345%. Molecular testing showed no detectable BRAF mutation. Dermatological assessment and systemic imaging identified no alternative primary melanoma or evidence of distant metastatic disease at initial staging. The patient underwent radical hysterectomy with bilateral pelvic lymphadenectomy and para-aortic lymphadenectomy and omental biopsy. Pelvic lymphadenectomy included bilateral external iliac nodal dissection, with no metastatic involvement identified in the examined lymph nodes. Postoperative pembrolizumab was subsequently initiated. Despite apparently localized disease and multimodal treatment, biopsy-confirmed vaginal recurrence developed approximately two months after surgery. Restaging\n 18<\/jats:sup>\n F-FDG PET\/CT demonstrated metabolically active disease involving the vaginal cuff and vagina, together with findings suspicious for external iliac nodal and hepatic involvement. Palliative external-beam radiotherapy was subsequently administered for hemostatic and locoregional control.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n This case highlights the aggressive and unpredictable course of PMMC, with early histologically confirmed recurrence following radical surgery and postoperative immune checkpoint inhibition. The rapid progression observed in our patient, considered alongside the heterogeneous responses to PD-1 blockade reported in the literature, underscores the therapeutic uncertainty surrounding this rare malignancy and the need for improved predictors of treatment response.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fonc.2026.1970684","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:28:03Z","timestamp":1789964883000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Primary malignant melanoma of the uterine cervix with early recurrence following radical surgery and immunotherapy"],"prefix":"10.3389","volume":"16","author":[{"given":"Alexandru-George","family":"Filipescu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Elias University Emergency Hospital","place":["Bucharest, Romania"]},{"name":"Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Cioca","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Gabriel","family":"Strajean","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Lungu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Boiangiu","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Elias University Emergency Hospital","place":["Bucharest, Romania"]},{"name":"Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy","place":["Bucharest, Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/biology12030398","article-title":"Primary melanoma of the cervix uteri: a systematic review and meta-analysis of the reported cases","volume":"12","author":"Kechagias","year":"2023","journal-title":"Biol (Basel)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.913964","article-title":"Primary Malignant melanoma of the cervix: an integrated analysis of case reports and series","volume":"12","author":"Min","year":"2022","journal-title":"Front Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01453-x","article-title":"Mucosal melanoma: epidemiology, clinical features, and treatment","volume":"25","author":"Sergi","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.9258","article-title":"Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis","volume":"35","author":"D'Angelo","year":"2017","journal-title":"J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.5468\/ogs.2018.61.4.524","article-title":"Primary Malignant melanoma of the uterine cervix treated with pembrolizumab after radical surgery: a case report and literature review","volume":"61","author":"Kim","year":"2018","journal-title":"Obstet Gynecol Sci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1400257","article-title":"Primary cervical Malignant melanoma that was successfully treated with pembrolizumab: a case report and literature review","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2026.1803729","article-title":"Primary Malignant melanoma of the uterine cervix: a case report of aggressive progression despite multimodal therapy","volume":"16","author":"Yu","year":"2026","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/PGP.0000000000000480","article-title":"Primary cervical Malignant melanoma: 2 cases and a literature review","volume":"38","author":"Yin","year":"2019","journal-title":"Int J Gynecol Pathol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1970684\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:28:03Z","timestamp":1789964883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1970684\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":8,"alternative-id":["10.3389\/fonc.2026.1970684"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1970684","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1970684"}}